Associated Papers
The Influence of OPRM1 A118G Polymorphism on the Dosage of Morphine in Patients with Advanced Liver Cancer.
Cheng H et al.
Journal of the College of Physicians and Surgeons--pakistan : Jcpsp, 2021
Overview of Genetic Analysis of Human Opioid Receptors.
Spampinato SM
Methods in Molecular Biology (clifton, N.j.), 2021
Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
Knapman A et al.
British Journal of Pharmacology, 2015
Mu opioid receptor gene: new point mutations in opioid addicts.
Dinarvand A et al.
Basic and Clinical Neuroscience, 2014
The mutational landscape of adenoid cystic carcinoma.
Ho AS et al.
Nature Genetics, 2013
Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2013
The genetics of the opioid system and specific drug addictions.
Levran O et al.
Human Genetics, 2012
Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids.
Diatchenko L et al.
European Journal of Pain Supplements, 2011
The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugs.
Fortin JP et al.
Molecular Pharmacology, 2010
OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.
Mague SD et al.
Drug and Alcohol Dependence, 2010
Novel linkage disequilibrium of single nucleotide polymorphisms in the transcriptional regulatory region of micro-opioid receptor gene in Japanese population.
Ono T et al.
Biological & Pharmaceutical Bulletin, 2009
Interindividual variability of methadone response: impact of genetic polymorphism.
Li Y et al.
Molecular Diagnosis & Therapy, 2008
[Are polymorphisms in the mu-opioid receptor important for opioid therapy?].
Lötsch J et al.
Schmerz (berlin, Germany), 2005
COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.
Goldman D et al.
Journal of Studies on Alcohol. Supplement, 2005
Principles of pharmacogenetics--implications for the anaesthetist.
Iohom G et al.
British Journal of Anaesthesia, 2004
Association of mu-opioid receptor subunit gene and idiopathic generalized epilepsy.
Wilkie H et al.
Neurology, 2002
A polymorphism (A118G) in the mu-opioid receptor gene affects the response to morphine-6-glucuronide in humans.
Höllt V
Pharmacogenetics, 2002
Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants.
Xin L et al.
Aaps Pharmsci, 2002
Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding.
Wang D et al.
The Journal of Biological Chemistry, 2001
A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling.
Befort K et al.
The Journal of Biological Chemistry, 2001
Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.
Hoehe MR et al.
Human Molecular Genetics, 2000